Mark Cuban Cost Plus Drug Co., EmsanaRx partner to bring lower-cost medicines to employers - Dallas Business Journal

日本 ニュース ニュース

Mark Cuban Cost Plus Drug Co., EmsanaRx partner to bring lower-cost medicines to employers - Dallas Business Journal
日本 最新ニュース,日本 見出し

The collaboration also serves as a transition for Cost Plus Drugs from the direct-to-consumer-market to the employer market.

  • 📰 DallasBizNews
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Cost Plus Drug Co. has partnered with Kentucky-based EmsanaRx to make lower-cost medicines available to employers, according to a news release.

The partnership comes as a response to a growing desire among employers and health care purchasers to reduce wasteful spending and increase transparency. "Like Cost Plus Drugs, EmsanaRx is working to disrupt the current pharmacy supply chain to eliminate the unnecessary markup and profiteering that is burdening businesses and consumers with high drug costs,"said in a prepared statement.

The release states when employee members use prescription drug discount card options, employers lose access to critical information. Employees end up spending money on medications that don't apply to their health plan deductible. "Employers are increasing recognizing that they're being held hostage by a consolidated industry playing games that cost them more every year without adding value,"

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

DallasBizNews /  🏆 525. in JP
 

日本 最新ニュース, 日本 見出し



Render Time: 2025-01-14 06:12:27